Dark

Check out our Level2View

TTOO
T2 BIOSYSTEMS INC
stock OTC

EOD

Jul 14, 2026

0.000700USD+16.667%(+0.000100)133

Pre-market

0.00USD-100.000%(0.00)0

After-hours

0.00USD0.000%(0.00)0

OverviewHistoricalExchangesShortsNews

Jan 11, 2022

09:08AM EST T2 Biosystems Sees Q4 Sales $6.6M vs $5.95M Estimate; FY21 Sales $27.7M vs $26.95M Est. Benzinga

09:05AM EST T2 Biosystems Announces Initiation Of T2Resistance Panel Clinical Trial Benzinga

09:05AM EST T2 Biosystems, Inc.(NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens, today announced preliminary unaudited financial and operational results for the fourth quarter and full year 2021. GlobeNewswire Inc

09:03AM EST T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens, today announced the initation of a U.S. clinical trial evaluating the performance of its T2Biothreat Panel designed to support a submission to the U.S. Food and Drug Administration (FDA). GlobeNewswire Inc

09:00AM EST T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens, today announced the initiation of a U.S. multi-site clinical trial evaluating the performance of its T2Resistance Panel designed to support a submission to the U.S. Food and Drug Administration (FDA). GlobeNewswire Inc

Dec 1, 2021

09:17AM EST Benzinga Pro's Top 4 Stocks To Watch For Wednesday, Dec. 1, 2021: RIOT, BYSI, AUVI, TTOO Benzinga

09:04AM EST T2 Biosystems Reports Its T2SARS-CoV-2 Panel Detects Omnicron Variant Benzinga

09:00AM EST T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens, today announced that its T2SARS-CoV-2Panel detects the Omicron COVID-19 variant (B.1.1.529). GlobeNewswire Inc

Nov 19, 2021

09:01AM EST T2 Biosystems Announces Exclusive Distribution Agreement In Taiwan To Sell T2Dx Instruments Along With T2Bacteria, T2Candida And T2Resistance Panels Through Distributor Benzinga

09:00AM EST T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens, today announced the execution of a territory exclusive distribution agreement in Taiwan. GlobeNewswire Inc

Nov 15, 2021

08:00AM EST T2 Biosystems, Inc.(NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens, today announced plans to participate in the upcoming Canaccord Genuity Virtual MedTech, Diagnostics and Digital Health & Services Forum. GlobeNewswire Inc

Nov 8, 2021

08:00AM EST T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens, announced it will participate in the 7th annual World Anti-Microbial Resistance Congress (WAMR) taking place on November 8 and 9 in Washington, DC. GlobeNewswire Inc

Nov 5, 2021

09:31AM EDT T2 Biosystems Raises FY21 Sales Guidance From $24M-$26M To $25M-$27M Vs. $25.02M Est. Benzinga

09:31AM EDT T2 Biosystems Q3 EPS $(0.08), Inline, Sales $7.40M Beat $5.68M Estimate Benzinga

Nov 4, 2021

05:00AM EDT Earnings Scheduled For November 4, 2021 Benzinga

Nov 3, 2021

11:05AM EDT Earnings Outlook For T2 Biosystems Benzinga

Oct 22, 2021

08:00AM EDT T2 Biosystems, Inc.(NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens, announced today that it will report financial results for the third quarter of 2021 after market close onThursday, November 4, 2021. Company management will host a corresponding conference call beginning at4:30 p.m. Eastern Time. GlobeNewswire Inc

07:36AM EDT The Daily Biotech Pulse: Athira CEO Resigns Over Doctored Research, Merck's Keytruda Snags First Approval For Breast Cancer In Europe, Minerva And Xilio IPOs Benzinga

06:10AM EDT The following are some of the stocks making big moves in Friday's pre-market trading (as of 05.50 A.M. EDT). RTTNews

Oct 21, 2021

04:14PM EDT T2 Biosystems Announces Distribution Agreements In Key Asia-Pacific Markets Benzinga

04:05PM EDT T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens, today announced the execution of territory exclusive distribution agreements in Singapore and South Korea. Under the terms of the agreements, T2 Biosystems will sell T2Dx Instruments, along with T2Bacteria, T2Candida and T2Resistance Panels through these distributors. GlobeNewswire Inc

Oct 19, 2021

04:05PM EDT T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens, today announced the appointment of Laura Adams to its Board of Directors, effective immediately. GlobeNewswire Inc

Oct 15, 2021

04:05PM EDT T2 Biosystems, Inc. (NASDAQ:TTOO) a leader in the rapid detection of sepsis-causing pathogens, announced today that it issued inducement awards to twenty new employees. GlobeNewswire Inc

Oct 14, 2021

08:56AM EDT T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens, today announced poster session and abstract data showcasing results of its rapid diagnostic technologies at several industry conferences throughout Sepsis Awareness Month. GlobeNewswire Inc

Oct 12, 2021

08:13AM EDT The Daily Biotech Pulse: NRx Stitches COVID-19 Drug Partnership, Protara Gets Nod For Starting Bladder Cancer Study, IGM Moves Beyond Oncology Benzinga

Oct 5, 2021

08:01AM EDT The Daily Biotech Pulse: J&J Files For Booster Dose Authorization, Gemini Restructures, Strata Skin CFO Departs, Kaleido Reports Positive Readout Benzinga

Oct 4, 2021

04:07PM EDT T2 Biosystems Announces BARDA Exercise Of Contract Option 2A Valued At $6.4M Benzinga

04:05PM EDT T2 Biosystems Announces BARDA Exercise of Contract Option 2A GlobeNewswire Inc

Oct 1, 2021

11:45AM EDT T2 Biosystems Has Been Awarded $6.3M BARDA Contract Option To Advance The Development Of Biothreat Detection Using T2MR Technology Benzinga

11:21AM EDT '[Health care-associated infections] have been on the rise with surges of #COVID19. Learn how T2Bacteria and T2Candida ID the most common secondary pathogens found in COVID-19 patients' -Tweet From T2 Biosystems Benzinga

Sep 14, 2021

10:06AM EDT T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens, today announced it will unveil new data at industry conferences this month to showcase results and implications of the use of its rapid diagnostics technologies. GlobeNewswire Inc

Sep 10, 2021

08:55AM EDT Benzinga Pro's Top 5 Stocks To Watch For Friday, Sept. 10, 2021: FCEL, AFRM, TTOO, APLS, ENDP Benzinga

08:00AM EDT The Daily Biotech Pulse: Apellis Sinks On Data, Endo Shines On Opioid Litigation Settlement, T2 Biosystems Soars On Mutant Detection Ability of COVID Test Benzinga

Sep 9, 2021

04:55PM EDT T2 Biosystems Says Its T2SARS-CoV-2 Panel Is Capable Of Detecting Mu And Iota Variants Of SARS-CoV-2 Benzinga

04:52PM EDT T2 Biosystems T2SARS-CoV-2Panel GlobeNewswire Inc

08:17AM EDT The Daily Biotech Pulse: ProQR-Lilly R&D Partnership, Sanofi's Pemphigus Trial Disappointment, Humanigen's COVID-19 Drug Denied Emergency Use Authorization Benzinga

Sep 8, 2021

05:23PM EDT T2 Biosystems Announces Plans to Consolidate and Expand Facilities in Massachusetts Benzinga

05:20PM EDT T2 Biosystems Announces Plans to Consolidate and Expand Facilities GlobeNewswire Inc

Sep 6, 2021

10:33AM EDT T2 Biosystems Earnings Perspective: Return On Capital Employed Benzinga

Sep 1, 2021

06:00PM EDT T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens, today announced efforts in recognition of Sepis Awareness Month to educate on the importance of rapid diagnostic technologies at a time when sepsis is the most common complication observed in severe cases of COVID-19.1,2 GlobeNewswire Inc

Aug 20, 2021

07:45AM EDT The Daily Biotech Pulse: J&J Announces CEO Transition, FibroGen's Roxadustat Approved In Europe, GeoVax, Sorrento Announce COVID-19 Vaccine Data Benzinga

Aug 18, 2021

07:38AM EDT The Daily Biotech Pulse: AzurRx Jumps On Data, Agios' Regulatory Application For Mitapivat Accepted For Priority Review, FDA Nod For GlaxoSmithKline Benzinga

Aug 17, 2021

08:28AM EDT The Daily Biotech Pulse: Lilly Reorganizes Business Units In Neuroscience Focus, Helius Medical Spikes On Breakthrough Designation, Ra Medical Sells Dermatology Business Benzinga

Aug 11, 2021

08:48AM EDT 'A recent poster presentation at #ECCMID2021 from The University of Lille in France showed that using the T2Candida Panel for high-risk patients in the ICU improved the diagnosis of invasive candidiasis.' -Tweet From T2 Biosystems Benzinga

Aug 5, 2021

05:33PM EDT T2 Biosystems Cuts Product Revenue Guidance From $16M-$18M, Driven By T2SARS-CoV-2 Panel Sales Benzinga

05:33PM EDT T2 Biosystems Q2 EPS $(0.08), Inline, Sales $6.70M Beat $6.12M Estimate Benzinga

08:08AM EDT The Daily Biotech Pulse: Merck Reports Positive Keytruda Readout, Moderna Slips Despite Q2 Beat, Bayer To Buy Vividion For Up To $2B, GlycoMimetics Gets New CEO Benzinga

04:08AM EDT Earnings Scheduled For August 5, 2021 Benzinga

Aug 1, 2021

11:19AM EDT The Week Ahead In Biotech (Aug. 1-7): Biopharma Earnings Pick Up Pace, Eton Awaits FDA Decision, Focus On Pending Clinical Readouts and IPOs Benzinga

Jul 23, 2021

04:06PM EDT T2 Biosystems 8-K Shows Co. Chair, John McDonough, Resigned; Pres, CEO, John Sperzel, Named Successor As Chair Benzinga

Jul 22, 2021

04:05PM EDT T2 Biosystems, Inc.(NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens, announced today that it will report financial results for the second quarter of 2021 after market close onThursday, August 5, 2021. Company management will host a corresponding conference call beginning at4:30 p.m. Eastern Time. GlobeNewswire Inc

09:39AM EDT '#T2Bio offers the only FDA-cleared, non-culture-based diagnostic panels that provide species ID in 3-5 hours direct from whole blood, often before the second dose of ABX is administered. This enables clinicians to initiate targeted therapy...' Benzinga

Jul 20, 2021

08:20AM EDT The Daily Biotech Pulse: Ardelyx Sinks On Regulatory Setback, AnPac Issues Positive Preannouncement, European Nod For Myovant, HCW Biologics Debuts On Wall Street Benzinga

Jul 19, 2021

05:00PM EDT T2 Biosystems, Inc. (NASDAQ:TTOO) a leader in the rapid detection of sepsis-causing pathogens, announced today that it issued inducement awards to eleven new employees. GlobeNewswire Inc

Jun 21, 2021

08:00AM EDT T2 Biosystems, Inc.(NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens, today announced the Companys participation in three virtual conferences this summer. GlobeNewswire Inc

Jun 11, 2021

09:19AM EDT ISS And Glass Lewis Recommend T2 Biosystems Stockholders Vote For Charter Amendment Proposal RTTNews

09:04AM EDT T2 Biosystems Reports ISS, Glass Lewis Recommend Co. Shareholders Vote For Charter Amendment Proposal To Increase Authorized Number Of Common Shares Benzinga

09:00AM EDT Worlds Leading Proxy Advisory Firms ISS and GlobeNewswire Inc

May 25, 2021

04:46PM EDT T2 Biosystems, Inc.(NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens, today reminded stockholders to vote at the upcoming 2021 Annual Meeting of Stockholders to be held on June 25, 2021. The T2 Biosystems Board of Directors unanimously supports each stockholder proposal on the proxy and encourages all stockholders to vote for these proposals. GlobeNewswire Inc

May 7, 2021

07:40AM EDT The Daily Biotech Pulse: Split Verdict For Chemocentryx, NKarta-CRISPR In Cell Therapy Collaboration, Orphazyme's Clinical Trial Setback, 2 IPOs Benzinga

May 6, 2021

04:34PM EDT T2 Biosystems Reports Co. Modified Terms Of Existing Contract With Biomedical Advanced Research and Development Authority (BARDA) To Accelerate Development Of Multiple Products Being Funded Under Contract Benzinga

04:32PM EDT Recap: T2 Biosystems Q1 Earnings Benzinga

04:31PM EDT T2 Biosystems Sees FY21 Revs $24M-$26M Benzinga

04:30PM EDT T2 Biosystems Q1 EPS $(0.07), Inline, Sales $6.96M Beat $6.44M Estimate Benzinga

07:49AM EDT The Daily Biotech Pulse: Merck's Keytruda Snags Another FDA Approval, Moderna Slips On Revenue Miss, Chemocentryx Adcom Benzinga

04:17AM EDT Earnings Scheduled For May 6, 2021 Benzinga

Apr 27, 2021

08:01AM EDT T2 Biosystems Announces Meta-Analysis Of Controlled Studies In Peer-Reviewed Medical Journal 'Highlighting The Benefits Of T2MR Technology Compared To Blood Culture' Benzinga

08:00AM EDT T2 Biosystems Announces Meta-analysis of Controlled Studies in GlobeNewswire Inc

Apr 22, 2021

04:05PM EDT T2 Biosystems, Inc.(NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens, announced today that it will report financial results for the first quarter of 2021 after market close onThursday, May 6, 2021. Company management will host a corresponding conference call beginning at4:30 p.m. Eastern Time. GlobeNewswire Inc

Apr 8, 2021

10:25AM EDT 'Division of Healthcare Quality Promotion reported CLABSI rates spiked by 28% in 2020. #T2Bio detects most CLABSIs in 3-5 hours, without raising your rates' -Tweet From T2 Biosystems Benzinga

Mar 30, 2021

08:00AM EDT All proceeds from the book sale will be donated to Sepsis Alliance and Donate Life America GlobeNewswire Inc

Mar 29, 2021

10:43AM EDT T2 Biosystems Shares See Volume; Co Granted European Patent Titled 'METHODS FOR AMPLIFYING AND DETECTING PATHOGEN NUCLEIC ACID IN A WHOLE BLOOD SAMPLE' Benzinga

Mar 26, 2021

04:05PM EDT T2 Biosystems, Inc. (NASDAQ:TTOO) a leader in the rapid detection of sepsis-causing pathogens, announced today that it issued inducement awards to eighteen new employees. GlobeNewswire Inc

Mar 4, 2021

04:27PM EST Recap: T2 Biosystems Q4 Earnings Benzinga

04:17PM EST T2 Biosystems Sees FY21 Sales $24M-$26M May Not Compare To $33.27M Est. Benzinga

04:15PM EST T2 Biosystems Q4 EPS $(0.07), Inline, Sales $7.80M Miss $7.96M Estimate Benzinga

04:05PM EST T2 Biosystems, Inc.(NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens, today announced financial results for the fourth quarter and full year ended December 31, 2020. GlobeNewswire Inc

08:12AM EST The Daily Biotech Pulse: FDA Nod For Pfizer, Kiniksa Rises On Commercialization Pact With Regeneron, Bio-Techne To Buy Diagnostic Company Benzinga

04:07AM EST Earnings Scheduled For March 4, 2021 Benzinga

Feb 27, 2021

09:04PM EST The Week Ahead In Biotech (Feb. 28-March 6): KemPharm, Gilead FDA Decisions and More Earnings Benzinga

Feb 23, 2021

08:00AM EST T2 Biosystems, Inc.(NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens, announced today that it will report financial results for the fourth quarter and full year 2020 after market close onThursday, March 4, 2021. Company management will host a corresponding conference call beginning at4:30 p.m. Eastern Time. GlobeNewswire Inc

Feb 11, 2021

11:21AM EST T2 Biosystems Shares Spike Higher On Slight Uptick In Volume Following Tweet From Co. '#CCC50 ends tomorrow! Stop by our virtual booth to download the latest T2SARS-CoV-2 brochure and learn more about how T2 Biosystems technology enables...' Benzinga

Feb 9, 2021

08:10AM EST The Daily Biotech Pulse: Dynavax Poaches GSK Vaccine Exec, KalVista Jumps On Data Readout, Corcept Issues Negative Preannouncement Benzinga

Feb 8, 2021

04:13PM EST T2 Biosystems Reports Will Participate In Upcoming BTIG Virtual MedTech, Digital Health, Life Science & Diagnostics Tools Conference Friday, Feb. 19, 2021 At 10 a.m. EST Benzinga

04:07PM EST T2 Biosystems, Inc.(NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens, today announced that the Company plans to participate in the upcoming BTIG Virtual MedTech, Digital Health, Life Science & Diagnostics Tools Conference. GlobeNewswire Inc

Feb 5, 2021

10:35AM EST ROCE Insights For T2 Biosystems Benzinga

07:44AM EST The Daily Biotech Pulse: J&J Files For COVID-19 Vaccine Approval, Zimmer Biomet's Spin-Off, IPO Deluge Hits Street Benzinga

Feb 4, 2021

04:32PM EST T2 Biosystems Says Its T2SARS-CoV-2 Panel Is Capable Of Detecting Brazil Variant Of SARS-CoV-2 Benzinga

04:05PM EST Panel is capable of detecting 99.99% of all currently identified SARS-CoV-2 viruses based on sequence alignments and in silico analysis GlobeNewswire Inc

Jan 29, 2021

04:05PM EST T2 Biosystems, Inc.(NASDAQ:TTOO), a global leader in the rapid detection of sepsis-causing pathogens, announced today that it issued an inducement award to Dr. Aparna Ahuja, the Companys recently appointed Chief Medical Officer, in accordance with the terms of Dr. Ahujas employment offer letter. GlobeNewswire Inc

Jan 27, 2021

11:26AM EST Alliance Global Partners Downgrades T2 Biosystems to Neutral, Lowers Price Target to $2.4 Benzinga

07:36AM EST The Daily Biotech Pulse: Sorrento, Immutep Surge On COVID-19 Study Data, T2 Biosystems Sinks On Preannouncement Benzinga

06:06AM EST T2 Biosystems Said on Jan 25, Entered Into Amendment No. 6 to Term Loan Agreement With CRG Servicing LLC, Extending Interest-only Payment Period From December 31, 2021 to December 31, 2022 Benzinga

05:29AM EST Pre-market Movers In Healthcare Sector: TMBR, AEZS, SRNE, RTTNews

05:25AM EST SVB Leerink Maintains Outperform on T2 Biosystems, Lowers Price Target to $3 Benzinga

Jan 26, 2021

04:46PM EST T2 Biosystems Sees Prelim. Q4 Sales $7.8M vs $9.01M Est., Sees FY20 Sales $18.1M vs $19.32M Est. Benzinga

04:45PM EST T2 Biosystems, Inc.(NASDAQ:TTOO), a global leader in the rapid detection of sepsis-causing pathogens, today announced preliminary unaudited financial and operational results for the fourth quarter and full year 2020. GlobeNewswire Inc

Jan 12, 2021

09:53AM EST Return On Capital Employed Overview: T2 Biosystems Benzinga

08:16AM EST The Daily Biotech Pulse: GSK, Vir To Start COVID-19 Antibody Study, Novartis In-Licenses BeiGene's Cancer Drug, Earnings Preannouncements Continue Benzinga

05:58AM EST T2 Biosystems Reported Monday, T2SARS-CoV-2 Panel Proves Effective Amid Global Rise in Variants of the SARS-CoV-2 Virus Benzinga

Jan 11, 2021

06:19PM EST Panel can detect multiple variants of the SARS-CoV-2 virus, including those most recently identified in the United Kingdom, South Africa, and the U.S. GlobeNewswire Inc

Jan 7, 2021

08:18AM EST T2 Biosystems Appoints Aparna Ahuja Chief Medical Officer RTTNews

08:09AM EST T2 Biosystems Appoints Industry Expert Aparna Ahuja, MD as Chief Medical Officer Benzinga

08:00AM EST T2 Biosystems, Inc.(NASDAQ:TTOO), a global leader in the rapid detection of sepsis-causing pathogens, today announced that its Board of Directors has appointed Aparna Ahuja, MD, as Chief Medical Officer (CMO), effective immediately. GlobeNewswire Inc

Dec 30, 2020

10:28AM EST Looking Into T2 Biosystems's Return On Capital Employed Benzinga

Nov 13, 2020

10:32AM EST T2 Biosystems Shares Quiet; Co Tweets 'We are actively searching for new team members to join our Research & Development team! The R&D team at T2 is behind the development of our innovative pipeline of products. View our job openings and apply today!' Benzinga

Nov 5, 2020

12:26PM EST Canaccord Genuity Maintains Buy on T2 Biosystems, Lowers Price Target to $3.5 Benzinga

07:54AM EST The Daily Biotech Pulse: Bluebird Bio Plunges On Regulatory Filing Delay, Synlogic Soars On Study Initiation, European Label Expansion For Vertex, Merck Goes Shopping Benzinga

04:08AM EST SVB Leerink Maintains Outperform on T2 Biosystems, Raises Price Target to $4 Benzinga

Nov 4, 2020

05:26PM EST T2 Biosystems: Q3 Earnings Insights Benzinga

04:34PM EST T2 Biosystems Sees Q4 Revenue Between $8.7M And $9.7M Benzinga

04:33PM EST T2 Biosystems Q3 EPS $(0.08), Inline, Sales $5.20M Beat $4.98M Estimate Benzinga

04:06PM EST T2 Biosystems, Inc.(NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens, today announced financial results for the third quarter ended September 30, 2020. GlobeNewswire Inc

08:21AM EST The Daily Biotech Pulse: Alzheimer's Conference Underway, Biogen's Aducanumab Briefing Doc, Supernus Earnings Benzinga

04:41AM EST Earnings Scheduled For November 4, 2020 Benzinga

Nov 1, 2020

09:40AM EST The Week Ahead In Biotech (Nov. 1-7): Adcom Test For Biogen's Aducanumab, Alzheimer's Conference, SMID-cap Earnings Benzinga

Oct 27, 2020

10:24AM EDT T2 Biosystems Shares Quiet; Co Tweets 'In the battle against sepsis, every hour counts. T2 Biosystems offers the only FDA-cleared tests that are directly from whole blood, and not predicated on blood culture positivity for the detection of...pathogens.' Benzinga

Oct 19, 2020

04:42PM EDT Sepsis Alliance Elects T2 Biosystems CEO as Advisory Board Member GlobeNewswire Inc

Oct 14, 2020

04:05PM EDT T2 Biosystems, Inc.(NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens, announced today that it will report financial results for the third quarter of 2020 after market close onWednesday, November 4, 2020. Company management will host a corresponding conference call beginning at4:30 p.m. Eastern Time. GlobeNewswire Inc

Oct 8, 2020

10:00AM EDT Benzinga's Top Upgrades, Downgrades For October 8, 2020 Benzinga

05:47AM EDT BTIG Initiates Coverage On T2 Biosystems with Buy Rating, Announces Price Target of $2.5 Benzinga

Oct 7, 2020

04:19PM EDT T2 Biosciences Shares Spike Higher; Hearing BTIG Initiates Coverage With Buy, $2.50 Price Target Benzinga

Sep 30, 2020

10:50AM EDT Why T2 Biosystems Stock Is Trading Higher Today Benzinga

09:01AM EDT T2 Biosystems Announces BARDA Exercise Of Contract Option 1 Valued At $10.5M Benzinga

09:00AM EDT T2 Biosystems, Inc.(NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens, announced today that the Biomedical Advanced Research and Development Authority (BARDA), part of the office of the Assistant Secretary for Preparedness and Response at the U.S. Department of Health and Human Services, has exercised its first contract option valued at $10.5 million. GlobeNewswire Inc

Sep 16, 2020

08:00AM EDT T2 Biosystems, Inc.(NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens, today announced that it is participating in the virtual, inaugural Sepsis Alliance Summit taking place September 16-17, 2020, through a sponsorship and virtual booth in honor of Sepsis Awareness Month (September). GlobeNewswire Inc

Sep 4, 2020

07:03AM EDT T2 Biosystems Announces CMS Approval Of New Technology Add-On Payment For The T2Bacteria Panel Benzinga

07:00AM EDT T2 Biosystems, Inc.(NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens, today announced that the U.S. Centers for Medicare & Medicaid Services (CMS) continued the New Technology Add-on Payment (NTAP) for the Companys T2BacteriaPanel for Fiscal Year 2021. GlobeNewswire Inc

Sep 1, 2020

10:11AM EDT Return On Capital Employed Overview: T2 Biosystems Benzinga

06:05AM EDT A Peek Into The Markets: US Stock Futures Edge Higher Following August's Rally; Manufacturing Data In Focus Benzinga

Aug 31, 2020

04:06PM EDT T2 Biosystems Receives FDA Emergency Use Authorization For Coronavirus Molecular Diagnostic Test Benzinga

04:05PM EDT T2 Biosystems, Inc.(NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens, today announced that the U.S. Food and Drug Administration (FDA) has issued Emergency Use Authorization (EUA) for its COVID-19 molecular diagnostic test, the T2SARS-CoV-2Panel. GlobeNewswire Inc

Aug 27, 2020

02:54PM EDT T2 Biosystems Move Higher; Co Tweets 'We are making progress following the launch of our COVID-19 molecular diagnostic test, the T2SARS-CoV-2 Panel! We are focused on supplying US hospitals & our customers are utilizing the test to diagnose #COVID19' Benzinga

Aug 26, 2020

09:36AM EDT T2 Biosystems Shares Move Higher; Co Tweets 'At T2 Biosystems, we continue to do our part to reduce the spread of #COVID19 by social distancing when possible and wearing our masks while continuing to manufacture and ship our life-saving technology.' Benzinga

Aug 24, 2020

11:12AM EDT Looking Into T2 Biosystems's Return On Capital Employed Benzinga

08:32AM EDT From Benzinga's PreMarket Prep: Co-Host Dennis Dick Says If He Was In Plasma Stocks Right Now He Would Sell Them; Notes 'This Is A Gift I Would Ring The Register Right Now' Benzinga

Aug 12, 2020

05:14AM EDT SVB Leerink Maintains Outperform on T2 Biosystems, Raises Price Target to $3 Benzinga

Aug 11, 2020

04:50PM EDT Recap: T2 Biosystems Q2 Earnings Benzinga

04:26PM EDT T2 Biosystems Q2 EPS $(0.09) Beats $(0.15) Estimate, Sales $2.55M Beat $2.37M Estimate Benzinga

04:05PM EDT T2 Biosystems, Inc.(NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens, today announced financial results for the second quarter ended June 30, 2020. GlobeNewswire Inc

04:02AM EDT Earnings Scheduled For August 11, 2020 Benzinga

Aug 10, 2020

11:08AM EDT Earnings Outlook for T2 Biosystems Benzinga

Aug 5, 2020

07:59AM EDT T2 Biosystems Announces Withdrawal Of Proxy Statement Proposal To Amend Its Certificate Of Incorporation To Authorize A Possible Reverse Stock Split Benzinga

07:30AM EDT T2 Biosystems Announces Withdrawal of Proxy Statement Proposal to GlobeNewswire Inc

Jul 29, 2020

01:16PM EDT T2 Biosystems Shares Spike Higher After Company Tweets Study Titled 'T2Bacteria panel in diagnostics of sepsis: the first experience at the University Hospital Centre Zagreb' (Link In Body) Benzinga

Jul 28, 2020

04:05PM EDT T2 Biosystems, Inc.(NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens, announced today that it will report financial results for the second quarter of 2020 after market close onTuesday, August 11, 2020. Company management will host a corresponding conference call beginning at4:30 p.m. Eastern Time. GlobeNewswire Inc

Jul 16, 2020

07:11AM EDT Canaccord Genuity Maintains Buy on T2 Biosystems, Raises Price Target to $4 Benzinga

Jul 14, 2020

08:06AM EDT T2 Bioystems Says On Jul. 1 Co. Submitted EUA Request To FDA For T2SARS-CoV-2 Panel Benzinga

Share